FreeSatireTrials & Tribulations The imaginary interview(with apologies to Molière, aka Jean-Baptiste Poquelin) May 11, 2018Vol.44 No.19By Derek Raghavan
FreeObituary Jane Reese-Coulbourne, advocate, consultant, industry executive, dies at 63 May 11, 2018Vol.44 No.19
Conversation with The Cancer LetterFree BMS’s Saha: We’re at the start of defining new endpoints, hypotheses with real-world evidence May 04, 2018Vol.44 No.18By Matthew Bin Han Ong
Free Flatiron, BMS form collaboration to curate regulatory-grade real-world data May 04, 2018Vol.44 No.18By Matthew Bin Han Ong
FreeIn Brief National Coalition for Cancer Research to cease operations as member groups take on their own education, policy roles May 04, 2018Vol.44 No.18
FreeIn Brief Campaign to educate Washington, DC, public about clinical trials May 04, 2018Vol.44 No.18
FreeFunding Opportunities CPRIT announces New Seed Award for early-stage oncology startups May 04, 2018Vol.44 No.18
Drugs & TargetsFree Novartis’ Kymriah gets second FDA approval—for large B-cell lymphoma May 04, 2018Vol.44 No.18
Drugs & TargetsFree FDA approves Tafinlar and Mekinist for BRAF V600-mutant melanoma May 04, 2018Vol.44 No.18
